Secondly, we investigated the relationship between MRTO4 expression and immune cell infiltration, IPS (immunophenoscore), TME (tumor microenvironment) score, TMB (tumor mutation burden), immune checkpoint gene expression, and drug sensitivity in HCC. The gene discussed is MRTO4; the disease is hepatocellular carcinoma.